Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Adenosine Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.98 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.98 |
| ▸ | P2RY1 | P47900 | 5/20 | 0.98 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.98 |
| ▸ | SRC | P12931 | 2/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.98 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.98 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.98 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.98 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.98 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.98 |
| ▸ | LDHA | P00338 | 1/20 | 0.98 |
| ▸ | FBP1 | P09467 | 1/20 | 0.98 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.98 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.98 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.98 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.98 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.98 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.98 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Phosphate SCHEMBL27502312 | 1.00 | P2RY1 (0.98) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL30012158 | 1.00 | P2RY1 (0.98) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL14478782 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL144997 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL13374692 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL19420134 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL1338615 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL20277555 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL132458 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL13170051 | 0.99 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116651412-A | Preparation method and application of Pickering emulsion interface-induced finite-domain polymeric imprinting adsorbent | 江苏大学 | 2023-08-29 | — | — | CN | claimed |
| WO-2022213447-A1 | PREPARATION METHOD FOR VIDARABINE MONOPHOSPHATE FREEZE-DRIED POWDER INJECTION | 海南锦瑞制药有限公司 | 2022-10-13 | — | — | WO | claimed |
| CN-114045275-A | Monophosphoryl adenylate enzyme and preparation method and application thereof | 云南省烟草农业科学研究院 | 2022-02-15 | — | — | CN | claimed |
| WO-2021252904-A1 | RIBONUCLEOPROTEIN APPROACH TO BOOST THE STING SIGNALING FOR CANCER IMMUNOTHERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-12-16 | — | — | WO | claimed |
| CN-112672763-A | Compositions and methods for metal-containing formulations capable of modulating immune responses | 密执安大学评议会 | 2021-04-16 | — | — | CN | claimed |
| CN-101107356-B | Enzymatic synthesis method of 3 '-adenosine phosphate-5' -phosphosulfate | YAMASA CORP | 2012-06-13 | — | — | CN | claimed |
| CN-101573447-A | Methionine synthases with reduced product inhibition | BASF SE (DE) | 2009-11-04 | — | — | CN | claimed |
| CN-110099905-B | Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-110088108-B | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024097804-A1 | COMBINATION OF A TYROSINE KINASE INHIBITOR AND A PRO-INFLAMMATORY AGENT FOR TREATING CANCER | MDX MANAGEMENT LLC (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-114045275-B | Adenosine monophosphate enzyme and preparation method and application thereof | 云南省烟草农业科学研究院 | 2024-05-07 | — | — | CN | disclosed |
| CN-111712503-B | Substituted tetrahydropyran dihydro-thienopyrimidines and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-112135791-B | Organically modified mineral particles, method for the production and use thereof | 禾大国际股份公开有限公司 | 2024-01-26 | — | — | CN | disclosed |
| US-5612060-A | Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1997-03-18 | — | — | US | disclosed |
| WO-1996000585-A1 | DIPHOSPHATE OR TRIPHOSPHATE ANALOGUE CONJUGATES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1996-01-11 | — | — | WO | disclosed |
| WO-1994004194-A1 | NUCLEIC ACID RECOGNITION AND TRANSPORT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1994-03-03 | — | — | WO | disclosed |
| US-5279664-A | Mixture of an amine compound, sodium and potassium hydroxide and chelate compound | ANGUS CHEMICAL COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
| WO-1993012050-A1 | DISPERSING AGENTS FOR COMMINUTED SOLIDS | ANGUS CHEMICAL COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| WO-1992020813-A1 | ASSAYS FOR FACTORS AFFECTING CIRCULARIZATION OF DNA, ASSAYS FOR FACTORS AFFECTING DNA INTEGRATION, FACTORS, AND USES THEREOF | DANA FARBER CANCER INSTITUTE (US) | 1992-11-26 | — | — | WO | disclosed |
| US-4345945-A | IN WATER, USING A MONO-, DE- OR TRI-SALT OF AN ALKANOLAMINE AND AN INORGANIC ACID OF PHOSPHORUS | INTERNATIONAL MINERALS & CHEMICAL CORP. (US) | 1982-08-24 | — | — | US | disclosed |